Table 1.
Parameters | Vehicle | 20 mg/kg/d | 40 mg/kg/d | 80 mg/kg/d | p |
---|---|---|---|---|---|
Incidence rate 1 | 100% | 100% | 100% | 100% | – |
Day of onset | 6.30 ± 0.37 | 9.00 ± 0.58** | 8.90 ± 0.48*** | 9.33 ± 1.14* | 0.011 |
Time of peak score | 13.40 ± 1.13 | 20.56 ± 2.21* | 13.10 ± 2.05 | 17.89 ± 2.62 | 0.038 |
Peak score | 2.20 ± 0.13 | 3.11 ± 0.48* | 1.50 ± 0.17 | 1.67 ± 0.17 | 0.001 |
Cumulative score | 54.50 ± 3.12 | 29.89 ± 3.90*** | 24.20 ± 3.48*** | 24.89 ± 3.62*** | <0.001 |
Statistical analysis was performed using one‐way anova followed by LSD post hoc test. Values were shown as mean ± SEM. Statistical significance: *p < 0.05, compared with vehicle‐treated mice; **p < 0.01, compared with vehicle‐treated mice; ***p < 0.001, compared with vehicle‐treated mice.
1Definition of successful induction of EAE: clinicalscore ≥ 1 was observed in neurological assessment with in 35 days.